# At-Home COVID-19 Antibody Test Usability Assessment & Behavior Change Study

> **NCT04393961** · NA · UNKNOWN · sponsor: **ProofPilot** · enrollment: 600 (estimated)

## Conditions studied

- COVID19
- COVID-19
- Coronavirus

## Interventions

- **DEVICE:** Premier Biotech COVID-19 IgG/IgM Rapid test Cassette

## Key facts

- **NCT ID:** NCT04393961
- **Lead sponsor:** ProofPilot
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-04-05
- **Primary completion:** 2020-07-29
- **Final completion:** 2020-08-29
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2020-05-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04393961

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04393961, "At-Home COVID-19 Antibody Test Usability Assessment & Behavior Change Study". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04393961. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*